Our partners benefit from the power of Atomwise's AI technology to identify diverse hits among billions of compounds, to increase potency and selectivity of hit ...

We Partnered Globally with Leading Researchers. We formed over 250 partnerships as part of our prior AIMS program with top universities and research institutes ...

17 авг. 2022 г. · Sanofi is continuing to push the limits of AI-powered drug discovery, inking a $1.2 billion biobucks research collaboration with Atomwise.

26 июн. 2020 г. · Atomwise is connecting researchers around the globe to their Artificial Intelligence Molecular Screen (AIMS) program. AtomNet, the company's ...

18 авг. 2022 г. · Atomwise and Sanofi entered a partnership to use the former's AI-driven AtomNet platform to discover and research up to five drug targets.

17 авг. 2022 г. · Sanofi will pay Atomwise $20 million upfront to identify, synthesize, and advance lead compounds for up to five targets which will be exclusive to Sanofi.

21 дек. 2020 г. · Atomwise-SEngine JV1: Atomwise and SEngine Precision Medicine's first joint venture combines AI technology and living tumor organoids to ...

22 июн. 2020 г. · “With Atomwise's AtomNet AI screening technology, more than 10 million small molecules can be virtually bound to PLpro,” Korotkov explained. “ ...

22 авг. 2022 г. · Atomwise has established a strategic and exclusive research collaboration with Sanofi that will leverage its AtomNet platform for computational discovery.

2 окт. 2023 г. · The San Francisco biotech is shifting its focus from inking hundreds of partnerships that use its AI technology to developing its own pipeline, ...